Announcement on Recognition of Subsidiary as High-tech Enterprise
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Recognition of Subsidiary as High-tech Enterprise
Filed with SSE · · 1 page · Chinese
Release
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix
Earlier from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Branch Receiving Pharmaceutical Registration Certificate in Macau
- Special Report on Deposit, Management and Actual Use of Raised Funds in 2025
- Announcement on Subsidiary Obtaining Notice of Approval for Drug Clinical Trials
- Announcement on Resignation of Vice Chairman
- Announcement on Progress in Subsidiary’s Acquisition of 100% Equity of Zhejiang Pharmaceutical Industry Corp., Ltd.
Later from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Resolutions of the 34th Meeting of the 9th Board of Directors
- Announcement on Change of Subsidiary's Drug Production License
- Announcement on Election of Board of Directors at Expiry of Term of Office
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Subsidiary
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
Follow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Baiyunshan Pharmaceutical